248 related articles for article (PubMed ID: 21911832)
21. Elevated International Normalized Ratio associated with concurrent use of ophthalmic erythromycin and warfarin.
Parker DL; Hoffmann TK; Tucker MA; Gerschutz GP; Malone PM
Am J Health Syst Pharm; 2010 Jan; 67(1):38-41. PubMed ID: 20044367
[TBL] [Abstract][Full Text] [Related]
22. End of study transition from study drug to open-label vitamin K antagonist therapy: the ROCKET AF experience.
Mahaffey KW; Hellkamp AS; Patel MR; Hannan KL; Schwabe K; Nessel CC; Berkowitz SD; Halperin JL; Hankey GJ; Becker RC; Piccini JP; Breithardt G; Hacke W; Singer DE; Califf RM; Fox KA
Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):470-8. PubMed ID: 23759472
[TBL] [Abstract][Full Text] [Related]
23. Clinical practice. Care of patients receiving long-term anticoagulant therapy.
Schulman S
N Engl J Med; 2003 Aug; 349(7):675-83. PubMed ID: 12917305
[No Abstract] [Full Text] [Related]
24. Leflunomide and warfarin interaction: case report and review of the literature.
Chonlahan J; Halloran MA; Hammonds A
Pharmacotherapy; 2006 Jun; 26(6):868-71. PubMed ID: 16716139
[TBL] [Abstract][Full Text] [Related]
25. Association Between Warfarin Control Metrics and Atrial Fibrillation Outcomes in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation.
Pokorney SD; Holmes DN; Thomas L; Fonarow GC; Kowey PR; Reiffel JA; Singer DE; Freeman JV; Gersh BJ; Mahaffey KW; Hylek EM; Naccarelli GV; Ezekowitz MD; Piccini JP; Peterson ED;
JAMA Cardiol; 2019 Aug; 4(8):756-764. PubMed ID: 31268487
[TBL] [Abstract][Full Text] [Related]
26. Postoperative acetaminophen and warfarin. Undesirable combination.
Elias M
Anesthesiology; 1998 Nov; 89(5):1296. PubMed ID: 9822039
[No Abstract] [Full Text] [Related]
27. Chitosan potentiation of warfarin effect.
Huang SS; Sung SH; Chiang CE
Ann Pharmacother; 2007 Nov; 41(11):1912-4. PubMed ID: 17925502
[TBL] [Abstract][Full Text] [Related]
28. Acetaminophen and risk factors for excess anticoagulation with warfarin.
Pedell L
JAMA; 1998 Aug; 280(8):696; author reply 697. PubMed ID: 9728632
[No Abstract] [Full Text] [Related]
29. Acetaminophen and risk factors for excess anticoagulation with warfarin.
Riser J; Gilroy C; Hudson P; McCay L; Willis TA
JAMA; 1998 Aug; 280(8):696; author reply 697. PubMed ID: 9728631
[No Abstract] [Full Text] [Related]
30. Acetaminophen and risk factors for excess anticoagulation with warfarin.
Amato MG; Bussey H; Farnett L; Lyons R
JAMA; 1998 Aug; 280(8):695-6; author reply 697. PubMed ID: 9728630
[No Abstract] [Full Text] [Related]
31. Acetaminophen and risk factors for excess anticoagulation with warfarin.
Gray CD
JAMA; 1998 Aug; 280(8):695; author reply 697. PubMed ID: 9728629
[No Abstract] [Full Text] [Related]
32. Acetaminophen and risk factors for excess anticoagulation with warfarin.
Estrada C
JAMA; 1998 Aug; 280(8):695; author reply 697. PubMed ID: 9728628
[No Abstract] [Full Text] [Related]
33. Clinical outcomes with rivaroxaban in patients transitioned from vitamin K antagonist therapy: a subgroup analysis of a randomized trial.
Mahaffey KW; Wojdyla D; Hankey GJ; White HD; Nessel CC; Piccini JP; Patel MR; Berkowitz SD; Becker RC; Halperin JL; Singer DE; Califf RM; Fox KA; Breithardt G; Hacke W
Ann Intern Med; 2013 Jun; 158(12):861-8. PubMed ID: 23778903
[TBL] [Abstract][Full Text] [Related]
34. Warfarin-acetaminophen interaction.
Med Lett Drugs Ther; 2008 Jun; 50(1288):45. PubMed ID: 18551088
[No Abstract] [Full Text] [Related]
35. Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study.
ROCKET AF Study Investigators
Am Heart J; 2010 Mar; 159(3):340-347.e1. PubMed ID: 20211293
[TBL] [Abstract][Full Text] [Related]
36. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
[TBL] [Abstract][Full Text] [Related]
37. A potential interaction between warfarin and atovaquone.
Hidalgo K; Lyles A; Dean SR
Ann Pharmacother; 2011 Jan; 45(1):e3. PubMed ID: 21189363
[TBL] [Abstract][Full Text] [Related]
38. Prevention of stroke in patients with atrial fibrillation.
Olsson SB; Halperin JL
Semin Vasc Med; 2005 Aug; 5(3):285-92. PubMed ID: 16123916
[TBL] [Abstract][Full Text] [Related]
39. Out-of-range INR values and outcomes among new warfarin patients with non-valvular atrial fibrillation.
Nelson WW; Wang L; Baser O; Damaraju CV; Schein JR
Int J Clin Pharm; 2015 Feb; 37(1):53-9. PubMed ID: 25428444
[TBL] [Abstract][Full Text] [Related]
40. Potentially lethal acetaminophen-warfarin interaction in an older adult: an under-recognized phenomenon?
Dharmarajan L; Sajjad W
J Am Med Dir Assoc; 2007 Oct; 8(8):545-7. PubMed ID: 17931583
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
